Catalyst

Slingshot members are tracking this event:

Leukemia Research presented at American Association for the Advancement of Science (AAAS) leads to boost for CAR-T developers

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
KITE

100%
BLUE

100%
CLLS

100%
ZIOP

100%
JUNO

100%
BLCM

100%
CYAD

100%
ADAP

100%

Additional Information

Management Comment "The last time [I saw] a change in remission rates like this must have been in 2000. [...] T-cells are a living drug, and in particular they have the potential to persist in our body for our whole lives"-Dr. Chiara Bonini
http://www.cnbc.com/...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 16, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Acute Lymphoblastic Leukemia, Car-t, Non-hodgkin's Lymphoma, Engineered T-cells